Skip to Content
HubMed
  • Solutions
    • Overview
    • Medea™
    • Adam™
  • Industries
    • Overview
    • Nutraceuticals
    • Cosmetics
    • Medical Devices
    • Contract Research Organization
  • Why Hubmed™
    • Overview
    • Swiss made quality
    • Data security
    • AI-Assisted
    • PICO Framework
    • End-to-End Integration
  • Resources
    • Blog
    • Press Room
    • Medea™ | Early Adopter Program
    • Medea™ | Referral Program
    • Medea™ | CER Maintenance Calculator
    • Medea™ | ROI & Savings
  • About Us
  • Contact Us 
HubMed
      • Solutions
        • Overview
        • Medea™
        • Adam™
      • Industries
        • Overview
        • Nutraceuticals
        • Cosmetics
        • Medical Devices
        • Contract Research Organization
      • Why Hubmed™
        • Overview
        • Swiss made quality
        • Data security
        • AI-Assisted
        • PICO Framework
        • End-to-End Integration
      • Resources
        • Blog
        • Press Room
        • Medea™ | Early Adopter Program
        • Medea™ | Referral Program
        • Medea™ | CER Maintenance Calculator
        • Medea™ | ROI & Savings
      • About Us
    • Contact Us 
  • All Blogs
  • Company News
  • HubMed Acting CEO Amedeo Chiappini to Join Expert Panel on Regulatory Scaling and Supply Chain Resilience at CPHI Milan
  • HubMed Acting CEO Amedeo Chiappini to Join Expert Panel on Regulatory Scaling and Supply Chain Resilience at CPHI Milan

    14 September 2026 by
    Marketing Hubmed

    As regulatory scrutiny intensifies across global markets, health and nutraceutical brands face a critical challenge: how do you scale product lines rapidly without creating bottlenecks in quality, compliance, or supply chain continuity?

    HubMed will address this exact challenge live at CPHI Milan 2026. In addition to being an Official Sponsor, Acting CEO Amedeo Chiappini, will participate as a featured speaker on an expert panel dedicated to nutraceutical compliance and supply chain resilience.


    Panel Session Overview

    • Session Topic: Nutraceuticals: Scaling Without Breaking Supply

    • Date & Time: October 8, 2026 | 10:30 AM – 11:15 AM

    • Location: Supply & Formulation Excellence Stage (Hall 2, Stand 2A132)

    • Featured Speaker: Amedeo Chiappini, Acting CEO & Co-Founder, HubMed Technologies


    Why Compliance is the Engine (Not the Brake) for Growth

    A single modification in botanical origin, extraction method, or supplier specification can instantly cascade into formulation changes, claims reassessments, and launch delays. During the panel, Amedeo will explore how bringing structured discipline into nutraceutical workflows does not mean slowing down innovation with heavy processes. Instead, it means establishing a connected, living evidence layer where quality, supplier qualification, and evidence appraisal stay continuously synchronized.

    By replacing fragmented, manual literature searches with AI-assisted workspace like Medea™, companies can substantiate claims, eliminate regulatory blind spots, and keep go-to-market timelines predictable.


    What You Will Gain from the Session

    • Connected Supply & Compliance: Understand why every supply-chain decision directly impacts product substantiation and labeling.

    • Evidentiary Rigor: Learn how to build traceable, defensible records for product claims under rising regulatory scrutiny.

    • Workflow Automation: Discover how embedding AI into scientific workflows reduces literature review and drafting time by up to 70% (~30 hours saved per report).


    Experience Medea™ Live at Stand 8S114

    Beyond the panel, the HubMed executive team will be hosted at Stand 8S114 (Start-Up Market Zone) throughout CPHI Milan.

    Stop by for live, interactive demonstrations of Medea™ to see firsthand how regulatory and R&D teams accelerate systematic literature reviews, streamline evidence appraisal and maintain audit-ready documentation.


    Claim a Free Visitor Pass & Book a Demo

    We have reserved a limited number of complimentary CPHI visitor passes for regulatory, QA, and R&D leaders.


    Claim your free CPHI pass & reserve a 1-on-1 demo with our team


    in Company News
    # AI Innovation Events Medea Nutraceuticals R&D Acceleration Swiss-Made AI
    USEFUL LINKS
    • Home
    • Solutions
    • Industries
    • Why Hubmed™
    • About us
      Privacy Policy
    • Contact us
    ABOUT US

    HubMed™ is a Swiss-made, AI-assisted platform for Life Sciences R&D and regulatory compliance, connecting preclinical discovery (Adam™) with clinical evaluation under EU MDR (Medea™). 

    It accelerates research-intensive work — literature search, screening, appraisal and structured drafting — while qualified experts stay in control of every scientific and regulatory decision.

    CONNECT WITH US
    • Contact us
    • info@hubmed.ch

    Follow us
    2026 Copyright © HubMed™ Technologies GmbH  |  Accelerating Discovery, Ensuring Compliance
    Powered by Odoo - Create a free website